Carcinoma in situ of skin of scalp and neck
ICD-10 D04.4 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of scalp and neck.
Carcinoma in situ (CIS) of the skin of the scalp and neck is a non-invasive form of skin cancer characterized by the presence of abnormal cells that have not yet invaded deeper tissues. This condition is often associated with sun exposure and can manifest as various skin lesions, including actinic keratosis or squamous cell carcinoma in situ. Patients may present with asymptomatic lesions that can appear as scaly patches, red spots, or non-healing sores. Early detection and treatment are crucial to prevent progression to invasive cancer. Treatment options typically include surgical excision, cryotherapy, or topical chemotherapy. Regular dermatological surveillance is recommended to monitor for changes in the lesions and to assess for new lesions, as individuals with a history of carcinoma in situ are at increased risk for developing subsequent skin cancers.
Detailed descriptions of lesions, treatment plans, and follow-up care.
Diagnosis and treatment of multiple skin lesions, monitoring for progression.
Ensure accurate documentation of lesion size, location, and characteristics.
Comprehensive treatment history and follow-up care documentation.
Management of patients with a history of skin cancers and surveillance protocols.
Coordination of care with dermatology for ongoing monitoring.
Used when a biopsy is performed to confirm carcinoma in situ.
Document the size, location, and type of biopsy performed.
Dermatologists should ensure clear documentation of the biopsy site and findings.
Carcinoma in situ refers to cancer cells that are confined to the layer of cells where they originated and have not invaded surrounding tissues. Invasive carcinoma has spread beyond the original layer into deeper tissues.
